Description: Polynovo Limited, a medical device company, designs, develops, and manufactures dermal regeneration solutions in Australia. The company focuses on the development and commercialization of medical devices using its NovoSorb technology in the treatment of burns, surgical wounds, and negative pressure wound therapy. It offers BTM (biodegradable temporising matrix), a wound dressing intended for treatment of full-thickness wounds and burns. In addition, Polynovo Limited licensed its NovoSorb to Smith & Nephew for orthopaedic applications. The company was formerly known as Calzada Limited and changed its name to Polynovo Limited in November 2014. Polynovo Limited is based in Port Melbourne, Australia.
Home Page: polynovo.com
320 Lorimer Street
Port Melbourne,
VIC
3207
Australia
Phone:
61 3 8681 4050
Officers
| Name | Title |
|---|---|
| Mr. Swami Raote BPHARM, M.B.A. | CEO & Director |
| Mr. Jan-Marcel Gielen C.A. | Chief Financial Officer |
| Dr. David McQuillan Ph.D. | Chief Technical & Scientific Officer |
| Mr. Philip Scorgie | Chief Information Officer |
| Mr. Lior Harel | General Counsel & Company Secretary |
| Ms. Ingrid Anderson | Chief People Officer |
| Mr. Edward Graubart | President of North America |
| Mr. Ahmed Hassan | Chief Manufacturing & Supply Chain Officer |
| Dr. Joseph F. Amaral M.D. | Chief Medical Officer |
| Mr. David N. Morris BAppSc, BBus | President of Asia Pacific |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 144.9275 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 21.0082 |
| Price-to-Sales TTM: | 9.3694 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 254 |